Keywords: Watson, Gedeon Richter, Mallinckrodt, Esmya, PregLem, Exalgo

Watson buys rights to Gedeon Richter’s Esmya; confirms Exalgo patent challenge

Article | 16 December 2010

Print This

Watson Pharmaceuticals (NYSE: WPI) this morning revealed that it has entered into an exclusive licensing agreement with PregLem SA, the ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in